Glaxo warns of birth defect from antiepileptic drug
Key points
- Drugmaker GlaxoSmithKline Plc. warned on Tuesday that there is an increased risk of cleft lip or cleft palate when the company's antiepileptic drug Lamictal is used during early pregnancy.
- The company, following discussions with Health Canada, said cleft palate deformity was detected at "an elevated rate" in infants whose mothers used the treatment during the first three months of pregnancy, compared with those who weren't exposed to the drug.
- Antiepileptic drugs have been associated with oral clefts, while other factors including smoking, heavy alcohol intake, various infections, folic acid deficiency, and vitamin A intoxication, have also contributed.
- The company advised patients who are being treated with Lamictal and who are, or intend to become pregnant, to discuss treatment with their doctors.
Drugmaker GlaxoSmithKline Plc. warned on Tuesday that there is an increased risk of cleft lip or cleft palate when the company's antiepileptic drug Lamictal is used during early pregnancy.
The company, following discussions with Health Canada, said cleft palate deformity was detected at "an elevated rate" in infants whose mothers used the treatment during the first three months of pregnancy, compared with those who weren't exposed to the drug.
Antiepileptic drugs have been associated with oral clefts, while other factors including smoking, heavy alcohol intake, various infections, folic acid deficiency, and vitamin A intoxication, have also contributed.
Oral clefts occur 0.5 to 2.16 times per 1,000 births.
The company advised patients who are being treated with Lamictal and who are, or intend to become pregnant, to discuss treatment with their doctors.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Addiction →NewsUniversity of Toronto scientists uncover how opioids cause dangerous breathing problems
University of Toronto researchers on a quest to make opioid drugs less lethal have discovered a window of opportunity: a tiny channel in the brain where opioids interfere with the breathing mechanism. They found that…
18 December 2015
NewsTesting for secondhand marijuana exposure
With increased legalization of marijuana for medicinal and recreational purposes, interest is growing in the potential health effects of its secondhand smoke. A team now reports in ACS' journal Analytical Chemistry the…
29 October 2015
NewsOnline gambling to get safer through better prediction of addiction
A new 'early warning' system that automatically informs gamblers as soon as their behaviour shows signs of turning into an addiction is helping people engage in the pastime responsibly. The system pinpoints whether a…
